Cytek Biosciences Inc
NASDAQ:CTKB
Cytek Biosciences Inc
NASDAQ:CTKB
Price:
6.38 USD
-0.62%
Market Closed
Updated:
May 8, 2024
Cytek Biosciences Inc
Cash from Investing Activities
|
Cytek Biosciences Inc
Cash from Investing Activities Peer Comparison
Comparables:
TMO
DHR
WST
A
IQV
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cytek Biosciences Inc
NASDAQ:CTKB
|
Cash from Investing Activities
-$93.9m
|
CAGR 3-Years
-293%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Investing Activities
-$5.1B
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-35%
|
|
|
Danaher Corp
NYSE:DHR
|
Cash from Investing Activities
-$7.1B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-18%
|
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Cash from Investing Activities
-$377.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-11%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Investing Activities
-$301m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-3%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Investing Activities
-$1.6B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-21%
|
See Also
What is Cytek Biosciences Inc's Cash from Investing Activities?
Cash from Investing Activities
-93.9m
USD
-93.9m
USD
Based on the financial report for Dec 31, 2023, Cytek Biosciences Inc's Cash from Investing Activities amounts to -93.9m USD.
What is Cytek Biosciences Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-293%
-293%
Over the last year, the Cash from Investing Activities growth was -68%. The average annual Cash from Investing Activities growth rates for Cytek Biosciences Inc have been -293% over the past three years .
You don't have any saved screeners yet
